Trauson Holdings, China's largest maker of pelvic reconstruction plates and other trauma surgery-related orthopedic products, is likely one of the next big medical device acquisition targets in that country, Bloomberg predicts. The reason: Trauson is in a space that stands to gain as China's massive elderly population expands in the coming years. Medtronic ($MDT) is already thinking ahead in this way, the article notes, with its recent $755 million purchase of China Kanghui Holdings, an orthopedic implant maker. China's orthopedic implant sales will virtually double by 2015, to $2.7 billion, according to Frost & Sullivan data cited by Bloomberg. More than 181 million senior citizens in China have artificial joints and implanted spinal devices, according to the story. Story